Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 34 UNKNOWN 3 OTHER_GOV 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 1019 Carboplatin 959 Paclitaxel 932 Gemcitabine 793 Cisplatin 748 Docetaxel 682 Bevacizumab 610 Pemetrexed 502 Nivolumab 486 Cyclophosphamide 466 Capecitabine 461 Fluorouracil 417 Dexamethasone 402 Rituximab 372 Oxaliplatin 347 Injections 342 atezolizumab 297 Trastuzumab 297 Leucovorin 286 Cetuximab 282 Irinotecan 266 130-nm albumin-bound paclitaxel 252 Prednisone 244 Doxorubicin 240 Ipilimumab 226 Lenalidomide 220 Fulvestrant 217 fludarabine 214 durvalumab 205 Erlotinib Hydrochloride 188

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Interventional × TP protocol × Clear all

NCT00680940 2012-08-07

NSCLC

Cadila Pharnmaceuticals

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡